medigraphic.com
ISSN 0188-2198 (Print)

2018, Number 2

<< Back Next >>

Rev Mex Cardiol 2018; 29 (2)

Prevalence of previous diagnosis of hypertension and associated factors in the Yaqui indigenous of Sonora

Castro-Juarez AA, Serna-Gutiérrez A, Lozoya-Villegas JF, Toledo-Domínguez IJ, Díaz-Zavala RG, Esparza-Romero J

Language: English
References: 29
Page: 90-97
PDF size: 295.68 Kb.


ABSTRACT

Introduction: The hypertension (HT) is a public health problem worldwide. This disease is a risk factor for heart diseases and, cerebrovascular and renal failure, which are considered the main causes of mortality. Objective: This study aimed to describe factors associated with a previous diagnosis of HT in a group of Yaqui adults from Sonora, Mexico. Material and methods: We conducted a cross-sectional epidemiological study in which 108 individuals ≥ 18 years of age were included. HT was considered as prior diagnosis. In addition, anthropometric assessment, medical history and sociodemographic questionnaires were also applied. The sex- and age adjusted prevalence was estimated using the direct method of standardization using the studied sample as the standard population. The factors associated with previous diagnosis of HT were determined using multiple logistic regression analysis. Results: The sex- and age-adjusted prevalence of a previous diagnosis of HT was 12.0% (95% CI: 6.3-17.6) in the overall population. The age-adjusted prevalence in men was 7.1%, and it was 14.0% in women with no significant difference between genders. The independent factors associated with HT were increased waist circumference (cm) (OR: 1.07, 95% CI: 1.01-1.14) and a previous diagnosis of diabetes (OR: 4.14, 95% CI: 1.03-16.61). Conclusions: The prevalence of a previous diagnosis of HT was high, and it could be higher after confirmation of new diagnosis cases in the population. The identification of factors associated with HT may be useful for creating programs to prevent chronic diseases in this ethnic group.


REFERENCES

  1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017; 389 (10064): 37-55.

  2. Stevens G, Dias RH, Thomas KJ, Rivera JA, Carvalho N, Barquera S et al. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med. 2008; 5 (6): e125.

  3. Tshitenge S, Mabuza LH. A survey of risk factors associated with hypertension in the adult population of Kang, Kgalagadi North, Botswana. S Afr Fam Pract. 2015; 57 (3): 177-182.

  4. World Health Organization. Global status report on non-communicable diseases 2010: description of the global burden of NCDs, their risk factors and determinants. World Health Organization; 2011. Available in: http://www.who.int/nmh/publications/ncd_report

  5. Hernández-Ávila M, Rivera-Dommarco J, Shamah-Levy T et al. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Resultados Nacionales. Cuernavaca. México: Instituto Nacional de Salud Pública (MX); 2016.

  6. King M, Smith A, Gracey M. Indigenous health part 2: the underlying causes of the health gap. Lancet. 2009; 374 (9683): 76-85.

  7. Moctezuma JL, Aguilar A. Los pueblos indígenas del Noroeste. México: INAH; 2013. p. 442.

  8. Rodríguez-Morán M, Guerrero-Romero F, Brito-Zurita O, Rascón-Pacheco RA, Pérez-Fuentes R, Sánchez-Guillén MC et al. Cardiovascular risk factors and acculturation in Yaquis and Tepehuanos Indians from Mexico. Arch Med Res. 2008; 39 (3): 352-357.

  9. Urquidez-Romero R, Esparza-Romero J, Chaudhari LS, Begay RC, Giraldo M, Ravussin E et al. Study design of the Maycoba Project: obesity and diabetes in Mexican Pimas. Am J Health Behav. 2014; 38 (3): 370-378.

  10. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006; 23 (5): 469-480.

  11. Kim Y, Radoias V. Education, individual time preferences, and asymptomatic disease detection. Soc Sci Med. 2016; 150: 15-22.

  12. Ashley EA, Niebauer J. Hypertension. Cardiology explained. London: Remedica; 2004. pp. 77-92.

  13. Campos-Nonato I, Hernández-Barrera L, Rojas-Martínez R, Pedroza A, Medina-García C, Barquera-Cervera S. Hipertensión arterial: prevalencia, diagnóstico oportuno, control y tendencias en adultos mexicanos. Salud pública Méx. 2013; 55 (Suppl 2): S144-S150.

  14. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición 2012. Resultados por entidad federativa, Sonora. Cuernavaca, México: Instituto Nacional de Salud Pública; 2013. (encuestas.insp.mx).

  15. Abdul-Razak S, Daher AM, Ramli AS, Ariffin F, Mazapuspavina MY, Ambigga KS et al. Prevalence, awareness, treatment, control and socio demographic determinants of hypertension in Malaysian adults. BMC Public Health. 2016; 16: 351.

  16. Nyuyki CK, Ngufor G, Mbeh G, Mbanya JC. Epidemiology of hypertension in Fulani indigenous populations-age, gender and drivers. J Health Popul Nutr. 2017; 36 (1): 35.

  17. Olives C, Myerson R, Mokdad AH, Murray CJ, Lim SS. Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009. PLoS One. 2013; 8 (4): e60308.

  18. Pérez-Escamilla R, Villalpando S, Shamah-Levy T, Méndez-Gómez HI. Household food insecurity, diabetes and hypertension among Mexican adults: Results from Ensanut 2012. Salud pública Méx. 2014; 56 (Suppl 1): s62-s70.

  19. Oliveira GF, Oliveira TR, Ikejiri AT, Andraus MP, Galvao TF, Silva MT et al. Prevalence of hypertension and associated factors in an indigenous community of central Brazil: a population-based study. PLoS One. 2014; 9 (1): e86278.

  20. Cardona-Arias JA, Llanes-Agudelo OM. Hipertensión arterial y sus factores de riesgo en indígenas Emberá-Chamí. CES Med. 2013; 27 (1): 31-43.

  21. Olinto MT, Nacul LC, Gigante DP, Costa JS, Menezes AM, Macedo S. Waist circumference as a determinant of hypertension and diabetes in Brazilian women: a population-based study. Public Health Nutr. 2004; 7 (5): 629-635.

  22. Yang L, Yan J, Tang X, Xu X, Yu W, Wu H. Prevalence, Awareness, Treatment, Control and Risk Factors Associated with Hypertension among Adults in Southern China, 2013. PLoS One. 2016; 11 (1): e0146181.

  23. Bhansali A, Dhandania VK, Deepa M, Anjana RM, Joshi SR, Joshi PP et al. Prevalence of and risk factors for hypertension in urban and rural India: the ICMR-INDIAB study. J Hum Hypertens. 2015; 29 (3): 204-209.

  24. Awoke A, Awoke T, Alemu S, Megabiaw B. Prevalence and associated factors of hypertension among adults in Gondar, Northwest Ethiopia: a community based cross-sectional study. BMC Cardiovasc Disord. 2012; 12: 113.

  25. Sampanis C, Zamboulis C. Arterial hypertension in diabetes mellitus: from theory to clinical practice. Hippokratia. 2008; 12 (2): 74-80.

  26. Naby M, Alione C, Alpha A et al. Prevalence and awareness of diabetes in Guinea: finding from a WHO STEPS. JEMDSA. 2017; 22: 36-42.

  27. Flores-Hernández S, Saturno-Hernández PJ, Reyes-Morales H, Barrientos-Gutiérrez T, Villalpando S, Hernández-Ávila M. Quality of diabetes care: the challenges of an increasing epidemic in Mexico. Results from Two National Health Surveys (2006 and 2012). PLoS One. 2015; 10 (7): e0133958.

  28. Hirmas Adauy M, Poffald-Angulo L, Jasmen-Sepúlveda AM, Aguilera-Sanhueza X, Delgado-Becerra I, Vega-Morales J. Barreras y facilitadores de acceso a la atención de salud: una revisión sistemática cualitativa. Rev Panam Salud Publica. 2013; 33 (3): 223-229.

  29. Hautecoeur M, Zunzunegui MV, Vissandjee B. Las barreras de acceso a los servicios de salud en la población indígena de Rabinal en Guatemala. Salud pública Méx. 2007; 49 (2): 86-93.




2020     |     www.medigraphic.com